In colon cancer cells, low concentrations of ET-1, either added exogenously or secreted by the tumour cells, are permissive for colon cancer cell survival, promoting resistance to FasL-mediated apoptosis, while high concentrations of either receptor antagonists or ET-1 promote apoptosis. Here, EDN1 is linked to malignant colon neoplasm.